PDLIM7, PDZ and LIM domain 7, 9260

N. diseases: 241; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia. 31633254 2020
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE An overlapping pattern of cerebral cortical thinning is associated with both positive symptoms and aggression in schizophrenia via the ENIGMA consortium. 31615588 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Recently, the ENIGMA-Schizophrenia DTI Working Group performed a large-scale meta-analysis and reported widespread white matter microstructural alterations in schizophrenia; however, no similar cross-disorder study has been carried out to date. 31780770 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE This study included 1985 individuals with schizophrenia from 17 research groups around the world contributing to the ENIGMA Schizophrenia Working Group. 28545597 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. 29038599 2018
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE In some of the largest neuroimaging studies to date - of schizophrenia and major depression - ENIGMA has found replicable disease effects on the brain that are consistent worldwide, as well as factors that modulate disease effects. 26658930 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE This prospective meta-analysis includes data from 1987 individuals with schizophrenia collected at seventeen centres around the world that contribute to the ENIGMA Schizophrenia Working Group. 28369804 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 Biomarker disease BEFREE This first ENIGMA Schizophrenia Working Group study validates that collaborative data analyses can readily be used across brain phenotypes and disorders and encourages analysis and data sharing efforts to further our understanding of severe mental illness. 26033243 2016
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.090 GeneticVariation disease BEFREE We also extracted the association between these 47 schizophrenia risk variants and the macroscopic structural brain volume (intracranial volume, total brain volume and hippocampal volume) in a large healthy sample of European ancestry (ENIGMA sample, N = 5,775). 26437209 2016